Bend, Oregon, US

Oral solid dose early development center

The Bend facility is our network’s center of excellence for solubility enhancement, advanced drug delivery, and early development. The campus is divided into three key buildings:

  • Building #1: Business services and cGMP manufacturing
  • Building #2: Analytical and formulation development
  • Building #3: Warehousing, receiving, shipping, and the quality control laboratory

Unique Offerings & Specialized Capabilities

  • Focus on early development: Supporting preclinical formulation through Phase IIb CTM
  • Expertise in solubilization, including AI/ML solubility enhancement with the proprietary Quadrant 2TM digital platform, spray drying, hot melt extrusion, and micronization technologies
  • Process scale-up and tech transfer expertise, leveraging DoE and compaction simulation technology
  • Predictive accelerated stability platform for determining product shelf life
  • Real-time dissolution monitoring and membrane flux testing
  • cGMP manufacturing for Phase I through Phase IIb CTM production

Formulation & Manufacturing Capabilities

  • Spray drying
  • Hot melt extrusion (HME)
  • Micronization
  • Tableting
  • Encapsulation
  • Coating
  • Milling and blending
  • Roller compaction
  • Compaction simulation
  • Packaging and labeling (non-blinded): bottles and blisters

Founded in 2007, the Bend facility has maintained full cGMP compliance since 2011.

For detailed information on the equipment and capabilities at this site, download our fact sheet.

Location Image

62925 NE 18th Street
Bend, OR 97701
Phone: +1 541 318 7115